Contributors

Contributors For 16 years, Carmen Sapienza has been a faculty member of Pathology and Laboratory Medicine at Temple University in Philadelphia. He says that once scientists sequenced the human genome, Mendelian diseases became more completely understood, however, most “people in hospital beds aren’t dying from Mendelian diseases.” There’s clearly a lot more to learn, and in "Sticky Fingers", Sapienza and his colleague Ionel Sandovic

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

For 16 years, Carmen Sapienza has been a faculty member of Pathology and Laboratory Medicine at Temple University in Philadelphia. He says that once scientists sequenced the human genome, Mendelian diseases became more completely understood, however, most “people in hospital beds aren’t dying from Mendelian diseases.” There’s clearly a lot more to learn, and in "Sticky Fingers", Sapienza and his colleague Ionel Sandovici (currently at the Babraham Institute in Cambridge, England), summarize new findings about a protein that may mark “hotspots,” or locations in the genome where most homologous recombination occurs. The protein may even play a role in speciation, they argue in the report (adapted from an article that appeared in F1000 Biology Reports).

Richard Morimoto became interested in proteins from an early age—while in high school, he created a science fair project on memory transfer. At the time, there was scientific literature suggesting that memory was coded in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies